{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "exchange": "KOE", "shortName": "Mezzion Pharma", "longName": "Mezzion Pharma Co.,Ltd.", "market": "kr_market", "marketState": "PREPRE", "earningsTimestamp": 1679569140, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "sharesOutstanding": 8546310, "fiftyDayAverage": 19333.6, "fiftyDayAverageChange": 5616.4004, "fiftyDayAverageChangePercent": 0.29049948, "twoHundredDayAverage": 15916.0, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": -3.6679535, "regularMarketPrice": 24950.0, "regularMarketChange": -950.0, "regularMarketTime": 1683873002, "regularMarketDayHigh": 26550.0, "regularMarketDayRange": "24800.0 - 26550.0", "regularMarketDayLow": 24800.0, "regularMarketVolume": 537482, "regularMarketPreviousClose": 25900.0, "bid": 24950.0, "ask": 24950.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 25950.0, "averageDailyVolume3Month": 711694, "averageDailyVolume10Day": 765324, "fiftyTwoWeekLowChange": 12700.0, "fiftyTwoWeekLowChangePercent": 1.0367347, "fiftyTwoWeekRange": "12250.0 - 29350.0", "fiftyTwoWeekHighChange": -4400.0, "fiftyTwoWeekHighChangePercent": -0.14991482, "fiftyTwoWeekLow": 12250.0, "fiftyTwoWeekHigh": 29350.0, "twoHundredDayAverageChange": 9034.0, "twoHundredDayAverageChangePercent": 0.5676049, "marketCap": 213230436352, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "firstTradeDateMilliseconds": 1327017600000, "priceHint": 2, "symbol": "140410.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "C&H Building", "address2": "3rd Floor 154-8 Samseong-dong Gangnam-gu", "city": "Seoul", "country": "South Korea", "phone": "82 2 560 8000", "fax": "82 2 563 6517", "website": "https://www.mezzion.co.kr", "industry": "", "sector": "", "longBusinessSummary": "Mezzion Pharma Co.,Ltd. engages in the development, licensing, and commercialization of drugs for the treatment of vascular diseases. It is developing Udenafil, a PDE5 inhibitor to treat erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension, overactive bladder, hepatic portal hypertension, and chronic obstructive pulmonary diseases. The company was formerly known as Dong-A Pharmtech Co., Ltd. and changed its name to Mezzion Pharma Co.,Ltd. in April 2013. Mezzion Pharma Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dong-Hyun  Park", "age": 66, "title": "Chairman, CEO & Pres", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Moo-Hi  Yoo", "age": 70, "title": "Chief Scientific Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. William  Breitenbach", "title": "Chief Commercial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}